ArticleFrontiers in oncology2020

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer.

Jiahong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.